David P. Wales Jr., deputy director of the Federal Trade Commission's Bureau of Competition, discussed how the FTC evaluates hospital mergers and pharmaceutical mergers and its ongoing investigations at The Deal's Healthcare Dealmaking Symposium. -
Maria Woehr
Continue reading below